TKNO Stock Price, Chart, Stats & News

Alpha Teknova, Inc.
Save
234.83M
Market cap
–
Current P/E
–
Forward P/E
TKNO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 33.17% |
Operating margin | -41.90% |
Pretax margin | -42.45% |
Net margin | -42.59% |
Effective tax rate | -0.34% |
ROA | -16.66% |
ROE | -23.32% |
D/E | 0.22x |
Interest coverage ratio | -23.91x |
TKNO valuation
P/E | – |
P/S | 3.58x |
P/B | 2.11x |
P/CF | -17.18x |
P/FCF | -15.14x |
P/OCF | -17.18x |
PEG | -1.43x |
EV multiple | -12.79x |
About
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples.
Similar securities
Based on sector and market capitalization
Report issue











